STAT3 and melanoma: An independent study confirmed these findings, revealing that p-STAT3 (Y705) stimulated anoikis resistance of B16-F10 melanoma cells as part of the FAK, p-ERK1/2 and PPARγ signalling pathways (Pei et al., 2017).